REG - Smith & Nephew Plc - Director/PDMR Shareholding

Smith & NephewAnnouncement

03/02/2021 17:01

RNS Number : 9242N
  
Smith & Nephew Plc
  
03 February 2021
  
 

SMITH & NEPHEW PLC
 
3 February 2021
 
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM.
 
Smith & Nephew plc (the "Company") announces that it has been informed of changes to the share interests of PDMRs in the Company, detailed below, following completion of the related performance periods. 
 
Smith & Nephew Global Share Plan 2010 (Performance Share Awards): 
 



Name of PDMR


Number of ordinary shares under award granted on 07/03/2018 (shown at maximum)


Number of ordinary shares lapsed under award (shown at maximum)




Bradley Cannon 


32,528


24,884




Phil Cowdy


15,494


11,853




Elga Lohler 


24,768


18,948




Catheryn O'Rourke 


24,548


18,780




Vasant Padmanabhan


                             27,894


21,339




Susan Swabey


10,920


8,354



 
Notes:
 
(i)      Following completion of the performance measurement period, 47% of the target awards made on 7 March 2018 vested.
 
(ii)     At maximum, 76.5% of awards have lapsed on 3 February 2021 and the remaining 23.5% of awards will vest and subject to continued employment, will be settled on 8 March 2021 being the first business date after the third anniversary of the awards.   
 
This announcement is made in accordance with the requirements of Article 19 (3) of the Market Abuse Regulation.
 
Vickie Reuben  
Deputy Company Secretary
Smith & Nephew plc
Tel:      +44 (0) 1923 477410

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
  END
 
 
DSHFLFERFEIVIIL